Taxanes in lung cancer: a review with focus on the European experience

Critical Reviews in Oncology/hematology
A Calderoni, T Cerny

Abstract

The introduction of new agents in the treatment of lung cancer raised in the past few years new interest in clinical research on this topic. The use of taxanes as paclitaxel and docetaxel may represent a significant progress in the treatment of lung cancer. Taxanes used as single agents show a substantial activity in lung cancer and, because of their unique mechanism of action, it is possible to combine these drugs with other non-cross-resistant agents. Taxanes share a radiosensitizing effect and their use with concurrent radiotherapy appears to become a new standard. This review will focus on the European clinical experience in the treatment of lung cancer with the two compounds.

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·R B TishlerE J Hall
Dec 12, 1992·Journal of the National Cancer Institute·R PazdurM M Bayssas
Nov 1, 1992·Investigational New Drugs·D R Spriggs, C Tondini
Feb 20, 1991·Journal of the National Cancer Institute·I Ringel, S B Horwitz
May 1, 1986·Cancer Treatment Reports·M G KrisC W Young
Jan 1, 1986·Annals of the New York Academy of Sciences·S B HorwitzR Zeheb
Jun 1, 1995·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·U GatzemeierA Dreps
Jun 1, 1995·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J Klastersky, J P Sculier
Jun 1, 1995·Seminars in Oncology·H Choy, M J Browne
Jul 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A C WolffD H Johnson
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J F SmythS B Kaye
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U BruntschM Bayssas
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F V FossellaB Glisson
Apr 13, 1995·The New England Journal of Medicine·E K Rowinsky, R C Donehower
Jan 1, 1994·Pharmacotherapy·D R Kohler, B R Goldspiel
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P A FrancisR T Heelan
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F V FossellaS Benner
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H ChoyL Leone
Mar 3, 1993·Journal of the National Cancer Institute·W K MurphyM N Raber
Oct 1, 1993·Cancer Treatment Reviews·R PazdurM N Raber
Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MillwardD R Bell
Oct 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R PirkerH Huber
Jan 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V AlberolaJ M Pérez
Dec 1, 1996·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·V WesteelA Depierre
Mar 4, 1998·Current Opinion in Cell Biology·M A Jordan, L Wilson
Aug 26, 1998·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·O P IsokangasK Mattson
Nov 3, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M I KoukourakisV Georgoulias
Jan 13, 1999·The Thoracic and Cardiovascular Surgeon·B HerseF Griesinger
Feb 4, 1999·The Annals of Thoracic Surgery·T W RiceE H Blackstone
Feb 16, 1999·International Journal of Radiation Oncology, Biology, Physics·M I KoukourakisV Georgoulias
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T Le ChevalierJ Bérille
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V GeorgouliasJ Vlachonicolis

❮ Previous
Next ❯

Citations

May 16, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Antonello CalderoniDaniel C Betticher
Dec 31, 2002·Critical Reviews in Oncology/hematology·Vicente AlberolaOscar Juan
Apr 25, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Nilufer Jasmine Selimah FauzeePan Juan
Jan 18, 2003·International Journal of Cancer. Journal International Du Cancer·Derrick S GrantAdam P Dicker
May 3, 2006·Medicinal Research Reviews·Ana R QuesadaMiguel A Medina
Jun 24, 2003·Biochemical Pharmacology·Richard A IsbruckerAmy E Wright

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Gastrointestinal Endoscopy
Mitsunobu MatsushitaKazuichi Okazaki
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
G J OssenkoppeleP C Huijgens
© 2021 Meta ULC. All rights reserved